Phathom Pharmaceuticals, Inc.
PHAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30 | -$76 | -$94 | -$74 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9 | $8 | $6 | $7 |
| Change in WC | -$2 | -$6 | -$9 | -$9 |
| Other Non-Cash | $8 | $11 | $13 | $13 |
| Operating Cash Flow | -$14 | -$63 | -$85 | -$63 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $25 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $0 | $0 | $1 |
| Financing Cash Flow | -$0 | $0 | $0 | $26 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14 | -$63 | -$85 | -$37 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $152 | $215 | $300 | $338 |
| End Cash | $138 | $152 | $215 | $300 |
| Free Cash Flow | -$14 | -$63 | -$85 | -$63 |